LEADER 02928nam 2200469 450 001 9910583337903321 005 20230120002745.0 010 $a0-12-809302-1 010 $a0-12-805353-4 035 $a(CKB)4100000001577946 035 $a(MiAaPQ)EBC5217571 035 $a(EXLCZ)994100000001577946 100 $a20180212h20182018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aNeuromodulation $ecomprehensive textbook of principles, technologies, and therapies /$fedited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai 205 $aSecond edition. 210 1$aLondon, England :$cAcademic Press,$d2018. 210 4$dİ2018 215 $a1 online resource (1,844 pages) $ccolor illustrations, tables 320 $aIncludes bibliographical references at the end of each chapters. 327 $aVolume 1. Section I: Defining neuromodulation -- Section II: The brain initiative: implications for a revolutionary change in clinical medicine via neuromodulation technology -- Section III: Fundamentals and mechanisms of neuromodulation -- Section IV: Technology and devices -- Section V: Brain, computer and machine interfacing -- Section VI: Emerging technologies and techniques -- Section VII: Surgical procedures and techniques -- Volume 2. Section VIII: Neuromodulation for pain control -- Section VIII A: Spinal cord stimulation for pain control -- Section VIII B: Peripheral nerve stimulation for pain control introduction: peripheral nerve stimulation for pain control -- Section VIII C: Intrathecal therapies for pain control and the control of spasticity -- Section VIII D: Intracranial procedures for chronic pain -- Section X: Neurostimulation for epilepsy -- Section XI: Neuromodulation for behavioral and cognitive disorders -- Volume 3. Section XII: Neuromodulation for functional restoration -- Section XIII: Neuromodulation for organ systems -- Section XIII A: Neuromodulation for cardiovascular disorders -- Section XIII B: Neuromodulation for pulmonary disorders -- Section XIII C: Neuromodulation for gastrointestinal disorders -- Section XIII D: Neuromodulation for urogenital disorders -- Section XIV: Neuromodulation for endocrine, immune, and inflammatory disorders -- Section XV: Noninvasive neuromodulation -- Section XVI: The business end of neuromodulation. 606 $aNeural transmission$xRegulation 606 $aNeurotransmitters 606 $aNeural stimulation 615 0$aNeural transmission$xRegulation. 615 12$aNeurotransmitters. 615 0$aNeural stimulation. 676 $a573.854 702 $aRezai$b Ali R. 702 $aPeckham$b P. Hunter 702 $aPeckham$b Elliot S. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910583337903321 996 $aNeuromodulation$91916100 997 $aUNINA